Header Logo

Connection

ERIC HOLZ to Genetic Therapy

Back to Details
This is a "connection" page, showing publications ERIC HOLZ has written about Genetic Therapy.
ERIC HOLZ
Connection Strength
0.046
Genetic Therapy
  1. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther. 2006 Feb; 17(2):167-76.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.